IP Library Granted Patent US 10,633,641
Granted Patent B2
US 10,633,641 · App. 15/959,839 · Granted Apr 28, 2020

Polymerase compositions, methods of making and using same

Inventors: Peter Vander Horn (Encinitas, CA); Theo Nikiforov (Carlsbad, CA); Guobin Luo (Oceanside, CA); Mindy Landes (Carlsbad, CA); Daniel Mazur (San Diego, CA); Eileen Tozer (San Diego, CA); Tommie Lloyd Lincecum (Carlsbad, CA)
Assignee: Life Technologies Corporation
C12N9/1252C12Q1/686C12Q1/6846C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,641
App. No.
15/959,839
Granted
Apr 28, 2020
Kind
B2
Abstract

The present disclosure provides compositions, methods, kits, systems and apparatus that are useful for nucleic acid polymerization. In particular, modified polymerases and biologically active fragment thereof are provided that allow for nucleic acid amplification. In one aspect, the disclosure relates to modified polymerases useful for nucleic acid sequencing, genotyping, copy number variation analysis, paired-end sequencing and other forms of genetic analysis. In some aspects, the disclosure relates to modified polymerases useful for the generation of nucleic acid libraries or nucleic acid templates for use in various downstream processes. In some aspects, the disclosure relates to the identification of homologous amino acid mutations that can be transferred across classes or families of polymerases to provide novel polymerases with altered catalytic properties. In some aspects, the disclosure provides modified polymerases having enhanced catalytic properties as compared to a reference polymerase.

Claims (20)

1. A modified polymerase consisting of the amino acid sequence of SEQ ID NO: 15 having any one of E471K, D732R, or E745Q amino acid substitutions, wherein the numbering is relative to the amino acid sequence of SEQ ID NO:15.

2. The modified polymerase of claim 1 , wherein the modified polymerase has the D732R substitution.

3. The modified polymerase of claim 1 , wherein the modified polymerase has the E745Q substitution.

4. The modified polymerase of claim 1 , wherein the modified polymerase has the E471K substitution.

5. A method for performing nucleic acid amplification, comprising: generating an amplification reaction mixture having a modified polymerase, a primer, a nucleic acid template, and one or more nucleotides, wherein the modified polymerase consists of the amino acid sequence of SEQ ID NO:15 having any one of E471K, D732R, or E745Q amino acid substitutions, wherein the numbering is relative to the amino acid sequence of SEQ ID NO:15; and subjecting the amplification reaction mixture to amplifying conditions, wherein at least one of the one or more nucleotides is polymerized onto the end of the primer using the modified polymerase to generate amplification products.

6. The method of claim 5 , wherein the amplifying conditions include the presence of a high ionic strength solution.

7. The method of claim 6 , wherein said high ionic strength solution comprises 100 mM to 500 mM salt.

8. The method of claim 7 , wherein the salt comprises NaCl and/or KCl.

9. The method of claim 5 , wherein the modified polymerase has the E471K substitution.

10. The method of claim 5 , wherein the modified polymerase has the E745Q substitution.

11. The method of claim 5 , wherein the modified polymerase has the D732R substitution.

12. The method of claim 11 , wherein the amplifying conditions include the presence of 100 mM to 200 mM salt.

13. The method of claim 5 , wherein the amplifying conditions include amplification of the nucleic acid template by a polymerase chain reaction.

14. The method of claim 5 , wherein the amplifying conditions include amplification of the nucleic acid template by a clonal amplification reaction.

15. The method of claim 5 , wherein the amplifying conditions include amplification of the nucleic acid template by an emulsion polymerase chain reaction.

16. The method of claim 15 , wherein the method further comprises subjecting the amplification products to a nucleic acid sequencing reaction.

17. The method of claim 5 , wherein the amplifying conditions include amplification of the nucleic acid template onto a solid support.

18. The method of claim 17 , wherein the method is performed on nucleic acid templates comprising the nucleic acid template to generate a nucleic acid library.

19. The method of claim 18 , wherein the method further comprises subjecting the nucleic acid library to a nucleic acid sequencing reaction.

20. The method of claim 19 , wherein the modified polymerase has the D732R substitution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: VANDER HORN, PETER; NIKIFOROV, THEO; LUO, GUOBIN; LANDES, MINDY; MAZUR, DANIEL; TOZER, EILEEN; LINCECUM, TOMMIE
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 045612/0123 →
Continuity (8)
Division 14754203 · Jun 29, 2015
Continuation 13572488 · Aug 10, 2012
Provisional Application 61522125 · Aug 10, 2011
Provisional Application 61545434 · Oct 10, 2011
Provisional Application 61585133 · Jan 10, 2012
Provisional Application 61643844 · May 7, 2012
Provisional Application 61681593 · Aug 9, 2012
Related Publication 20180305673A1 · Oct 25, 2018
Cited By (1)
US 12,338,465